Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 7/20 | 0.46 |
| ▸ | MME | P08473 | 1/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | LAP3 | P28838 | 2/20 | 0.41 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.41 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.40 |
| ▸ | CTSD | P07339 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leu-Ala SCHEMBL14117889 | 1.00 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL31696288 | 1.00 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL259115 | 1.00 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL29531953 | 1.00 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL14831225 | 1.00 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL2030930 | 1.00 | SLC7A5 (0.59) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL16863492 | 0.98 | SLC7A5 (0.57) | SLC7A5SLC1A3SLC1A2ACEMME | |
| Leu-Ala SCHEMBL3677363 | 0.98 | SLC7A5 (0.57) | SLC7A5SLC1A3SLC1A2ACEMME | |
| SCHEMBL30905089 | 0.96 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2ACEMME | |
| SCHEMBL29967576 | 0.96 | SLC7A5 (0.55) | SLC7A5SLC1A3SLC1A2ACEMME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 574 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2026-03-03 | — | — | US | claimed |
| CN-119355268-A | Application of two dipeptides in preparation of kit for diagnosing and distinguishing prostate cancer and benign prostatic hyperplasia | 中国药科大学 | 2025-01-24 | — | — | CN | claimed |
| US-20250027938-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-01-23 | — | — | US | claimed |
| EP-4483959-A2 | NOVEL PEPTIDE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | EYEBIO KOREA (KR) | 2025-01-01 | — | — | EP | claimed |
| EP-4424365-A2 | PET FOOD COMPOSITIONS | Hill's Pet Nutrition, Inc. (US) | 2024-09-04 | — | — | EP | claimed |
| EP-4017281-B1 | PET FOOD COMPOSITIONS | HILLS PET NUTRITION INC (US) | 2024-08-28 | — | — | EP | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-20240228538-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | EYEBIO KOREA (KR) | 2024-07-11 | — | — | US | claimed |
| WO-2024132725-A1 | SERUM PEPTIDE PATTERNS FOR DIAGNOSTICS OF INTRACRANIAL HEMORRHAGIC STROKE IN HUMANS AND DIFFERENTIAL DIAGNOSIS OF INTRACRANIAL HEMORRHAGIC STROKE FROM ACUTE ISCHEMIC STROKE | UNIWERSYTET GDANSKI (PL) | 2024-06-27 | — | — | WO | claimed |
| EP-4370919-A1 | METABOLIC SIGNATURE FOR PREDICTION OF MUCOSAL INFLAMMATION AND MICROBIAL COMPOSITION | Imperial College Innovations Limited (GB) | 2024-05-22 | — | — | EP | claimed |
| US-20180275144-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2018-09-27 | — | — | US | claimed |
| WO-2016124574-A1 | DIAGNOSTIC TOOLS FOR ALZHEIMER'S DISEASE | PHARNEXT (FR) | 2016-08-11 | — | — | WO | claimed |
| US-20160016929-A1 | PRO-DRUG COMPOUNDS | PROXIMAGEN LIMITED | 2016-01-21 | — | — | US | claimed |
| EP-2970226-A1 | PRO-DRUG COMPOUNDS | Proximagen Limited (GB) | 2016-01-20 | — | — | EP | claimed |
| WO-2014140510-A1 | PRO-DRUG COMPOUNDS | PROXIMAGEN LIMITED (GB) | 2014-09-18 | — | — | WO | claimed |
| EP-0412061-B1 | 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same | SIGMA TAU IND FARMACEUTI (IT) | 1994-10-05 | — | — | EP | claimed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| EP-0412061-A2 | 2-(N-acyl)amino-6,7-dimethoxy tetralines, process for their preparation and pharmaceutical compositions having antihypertensive activity containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1991-02-06 | — | — | EP | claimed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228538-A1 | Novel Peptide Compound Or Pharmaceutically Acceptable Salt Thereof | VIP, NPPA, NGLY1 | SLC7A5 129/4885SLC1A3 682/4885SLC1A2 2005/4885 |
| US-20160016929-A1 | PRO-DRUG COMPOUNDS | H1-0, ZYX, FURIN | SLC7A5 723/4885SLC1A3 1278/4885SLC1A2 2146/4885 |
| US-12566161-B2 | Methods and consumer products for detecting a metabolite | SLC6A6, SLC7A11, CTH | SLC7A5 40/4885SLC1A3 75/4885SLC1A2 102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.